Literature DB >> 15854216

Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients.

Willem Develter1, Antoine De Cubber, Wim Van Biesen, Raymond Vanholder, Norbert Lameire.   

Abstract

BACKGROUND: The risk factors influencing the survival of indwelling central vein catheters and their potential complications have not been assessed in depth and on a large scale.
METHODS: We investigated the general characteristics of 245 single lumen cuffed tunneled catheters and analyzed their survival by Kaplan-Meier and Cox regression analysis. Risk factors for bacteremia and thrombosis were assessed by logistic regression analysis.
RESULTS: The incidence of exit-site infection, tunnel infection, bacteremia and thrombotic events was 0.35, 0.25, 1.71, and 1.94/1000 catheter days, respectively. The mean survival time per catheter was 276 days. After censoring for non catheter-related events leading to the removal of the catheter (n = 245 with 120 catheters censored and 125 events), the mean survival time of the catheter appeared to be 615 +/- 67 days (95% CI of 483-747) and the median survival time 310 +/- 50 days (95% CI of 212-408). The localization of the catheter into the right internal jugular vein results in significantly better survival as compared with other insertion sites both in Kaplan-Meier (mean survival of 650 days compared to a mean survival of 519 days, P value < 0.009) and in Cox regression analysis (relative risk of 0.537, P value < 0.001). Localization of the catheter into the right internal jugular vein seemed to increase the risk for bacteremia (relative risk of 1.798, P value of 0.063). The use of anticoagulant agents was not protective for thrombosis, although this might be due to lack of power (relative risk of 0.626, P value of 0.141).
CONCLUSION: We provide evidence of a mean survival in long-term hemodialysis catheter close to 2 years with an acceptable complication rate. If a long-term hemodialysis catheter is required, it is best placed in the right internal jugular vein.

Entities:  

Mesh:

Year:  2005        PMID: 15854216     DOI: 10.1111/j.1525-1594.2005.29067.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  18 in total

1.  Low-intensity adjusted-dose warfarin for the prevention of hemodialysis catheter failure: a randomized, controlled trial.

Authors:  Trevor J Wilkieson; Alistair J Ingram; Mark A Crowther; Steven D Soroka; Ryuta Nagai; Kailash K Jindal; Catherine M Clase
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

2.  An economic evaluation of rt-PA locking solution in dialysis catheters.

Authors:  Braden J Manns; Nairne Scott-Douglas; Marcello Tonelli; Pietro Ravani; Martine LeBlanc; Marc Dorval; Rachel Holden; Louise Moist; Charmaine Lok; Deborah Zimmerman; Flora Au; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

3.  Use of iliac vein tunneled cuffed catheters in elderly hemodialysis patients: a single-center retrospective study.

Authors:  Lihua Wang; Fang Wei; Guijiang Sun; Haiyan Chen; Haibo Yu; Aili Jiang
Journal:  J Nephrol       Date:  2015-05-13       Impact factor: 3.902

4.  A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3.

Authors:  James Tumlin; Jesse Goldman; David M Spiegel; David Roer; K Adu Ntoso; Martha Blaney; Joan Jacobs; Barbara S Gillespie; Susan M Begelman
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-04       Impact factor: 8.237

5.  Longer duration of catheter patency, but similar infection rates with internal jugular vein versus iliac vein tunneled cuffed hemodialysis catheters: a single-center retrospective analysis.

Authors:  Lihua Wang; Fang Wei; Aili Jiang; Haiyan Chen; Guijiang Sun; Xueqing Bi
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

6.  Natural history of tunneled dialysis catheters placed for hemodialysis initiation.

Authors:  Roman Shingarev; Jill Barker-Finkel; Michael Allon
Journal:  J Vasc Interv Radiol       Date:  2013-07-18       Impact factor: 3.464

7.  Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage.

Authors:  Damien R Ashby; Albert Power; Seema Singh; Peter Choi; David H Taube; Neill D Duncan; Tom D Cairns
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-13       Impact factor: 8.237

8.  Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Steven D Soroka; Adeera Levin; Jennifer MacRae; Karthik Tennankore; Jo-Anne S Wilson; Robert G Weaver; Pietro Ravani; Robert R Quinn; Marcello Tonelli; Mercedeh Kiaii; Paula Mossop; Nairne Scott-Douglas
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-15       Impact factor: 8.237

9.  Rivaroxaban improves patency and decreases inflammation in a mouse model of catheter thrombosis.

Authors:  Christi M Terry; Yuxia He; Alfred K Cheung
Journal:  Thromb Res       Date:  2016-06-09       Impact factor: 3.944

10.  Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime.

Authors:  Mojgan Mortazavi; Samira Alsaeidi; Roohollah Sobhani; Fereshte Salimi; Abdolamir Atapour; Nima Sharif; Mojtaba Akbari; Bahram Pakzad; Amir Hosein Davarpanah Jazi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.